| |
|
2008 Metabolic Syndrome Institute Awards
|
 PURPOSE
To promote new talents and research themes in the field of metabolic syndrome, the Metabolic Syndrome Institute (MSI) intends to stimulate experimental and clinical research in the field of metabolic syndrome by granting three annual awards – The MSI Awards for Metabolic Syndrome Research – to scientists or clinicians who will have submitted the best scientific applications according to the MSI Award Jury.
ELIGIBILITY
The MSI Awards will be granted to young scientists or clinicians working in the field of metabolic syndrome, insulin resistance, and/or related cardiovascular risk assessment and prevention
AWARDS
For the year 2008, three successful applicants will be granted US $10,000 each or the equivalent in euros.
|
|
Metabolic Syndrome News
(from June 2008)
|
| Epidemiology |
 Body weight change as independent predictor of chronic kidney disease in healthy men
(Posted June 27, 2008) | View
Elevated serum uric acid as a strong and independent predictor of incident metabolic syndrome in both men and women
(Posted June 27, 2008) | View
Metabolic syndrome identifies patients at risk of both diabetes and cardiovascular disease who may derive benefit from lifestyle intervention
(Posted June 27, 2008) | View
Waist-to-hip ratio, but not body mass index, associated with incident kidney disease and mortality
(Posted June 27, 2008) | View
Sleep duration as a significant correlate of metabolic syndrome in midlife adults
(Posted June 27, 2008) | View
Dramatic increases in overweight and obesity rates between the ages of 1 and 3 years among low-income children from New York City
(Posted June 27, 2008) | View
The Multi-Ethnic Study of Atherosclerosis confirms the impact of obesity on cardiovascular disease risk factors
(Posted June 27, 2008) | View
|
| |
| Screening / Diagnosis |
|
One hour plasma glucose concentration as a strong predictor of future risk for type 2 diabetes
(Posted June 30, 2008) | View
|
| |
|
Pathophysiological Aspects
|
|
 A sex hormone alteration may underlie visceral fat accumulation and thus ultimately metabolic syndrome
(Posted June 26, 2008) | View
Lower sex hormone-binding globulin more strongly associated with metabolic syndrome than lower testosterone in older men
(Posted June 23, 2008) | View
Interacting genetic risk factors and smoking influence on metabolic disturbances in schizophrenic patients
(Posted June 17, 2008) | View
Metabolic syndrome may be relevant to the continuum of metaplasia observed in patients presenting with Barrett’s esophagus
(Posted June 13, 2008) | View
Variants in the fat mass and obesity associated (FTO) gene linked with polycystic ovary syndrome
(Posted June 12, 2008) | View
Inflammatory markers and albuminuria as independent predictors of incident heart failure
(Posted June 11, 2008) | View
Accumulation of intra-abdominal adiposity during adolescence promotes development of metabolic syndrome in both sexes but influences blood pressure adversely only in males
(Posted June 10, 2008) | View
Non-HDL cholesterol strongly associated with coronary artery calcification
(Posted June 6, 2008) | View
Higher visceral adipose tissue associated with higher VLDL and LDL particle number, larger VLDL particles and smaller LDL and HDL particles in type 2 diabetes
(Posted June 5, 2008) | View
|
| |
| Metabolic Syndrome Components / Risk Factors / Associated Risks |
HIGH BLOOD PRESSURE
Similar deleterious impact of metabolic syndrome on all-cause mortality in hypertensive and normotensive subjects
(Posted June 9, 2008) | View
|
| |
| Cardiovascular Morbidity and Mortality Associated with the Metabolic Syndrome |
|
DIABETES
Central obesity measured by computed tomography no better predictor of diabetes than body mass index
(Posted June 4, 2008) | View
|
| |
| Prevention and Treatment |
|
 Diet and weight loss shown to increase the number of circulating progenitor cells in obese patients
(Posted June 19, 2008) | View
Maintaining weight may be beneficial in older persons who become overweight after age 65
(Posted June 18, 2008) | View
|
|
|
Featured Upcoming Congresses
(August - December 2008)
|
| Australian Diabetes Society / ADEA Annual Scientific Meeting |
|
Date:
|
|
August 28-30, 2008 |
|
Location:
|
|
Melbourne, Australia |
|
Web site:
|
|
http://www.racp.edu.au/ads/meetings.htm |
| |
| ESC Congress 2008 |
|
Date:
|
|
August 30-September 3, 2008 |
|
Location:
|
|
Munich, Germany |
|
Web site:
|
|
http://www.escardio.org |
| |
| 2008 Cardiometabolic Health Congress |
|
Date:
|
|
October 15-18, 2008 |
|
Location:
|
|
Boston, MA |
|
Web site:
|
|
http://www.cardiometabolichealth.org/
|
| |
| 1st Diabetes in Asia Study Group Conference |
|
Date:
|
|
October 16-19, 2008 |
|
Location:
|
|
Kathmandu, Nepal |
|
Web site:
|
|
http://dasg.dapkhi.org/Default.aspx |
| |
| 2nd World Congress on Controversies in Diabetes, Obesity and hypertension (CODHy) |
|
Date:
|
|
October 30-November 2, 2008 |
|
Location:
|
|
Barcelona, Spain |
|
Web site:
|
|
http://www.codhy.com/codhy2/ |
| |
| XV International Symposium on Atherosclerosis |
|
Date:
|
|
June 14-18, 2009 |
|
Location:
|
|
Boston, MA, USA |
|
Web site:
|
|
http://www.isa2009.org/ |
|
|
Featured Trial
Trial - VALISH
(Valsartan in Elderly Isolated Systolic Hypertension)
Outcome:
Composite cardiovascular events: 1) sudden death; 2) fatal or non-fatal stroke; 3) fatal or non-fatal myocardial infarction; 4) death due to heart failure; 5) other cardiovascular death; 6) unplanned hospitalization for cardiovascular disease; 7) renal disorder
Expected total enrollment:
3000 patients with stable seated systolic blood pressure >160 mmHg and diastolic blood pressure <90 mmHg at two visits within 2 to 4 weeks.
Comparisons:
Valsartan and target blood pressure <140 mmHg vs valsartan and target blood pressure <150 mmHg.
Design:
Randomized, open-label, active control, parallel assignment.
Additional Information
> View all landmark studies and clinical trials
|
Framingham Risk Assessment Tool
Estimates 10-year risk of developing hard CHD
> View Tool
Procam Risk Calculator
Estimates your risk of a heart attack (myocardial infarction) within the next 10 years based upon data of the PROCAM Study
> View Calculator
SCORE
(European High Risk Chart)
Estimates 10 year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol and smoking status.
> View Chart
UKPDS Risk Engine
The UKPDS Risk Engine is a type 2 diabetes specific risk calculator based on 53,000 patients years of data from the UK Prospective Diabetes Study, which also provides an approximate 'margin of error' for each estimate.
> View Risk Engine
|
Mission of the Metabolic
Syndrome Institute |
|
Created in 2003, the Metabolic Syndrome Institute is an independent and not for profit association. Its members are international experts in lipid metabolism, diabetes, heart disease, endocrinology obesity, genetics, epidemiology, basic research and health economics. Being the first association totally devoted to the dissemination of knowledge about the metabolic syndrome, the Metabolic Syndrome Institute will provide an international multidisciplinary approach to a worldwide public health problem.
|
| |
|
Contact Metabolic Syndrome Institute
|
212, avenue Paul Doumer
92500 Rueil-Malmaison Cedex
FRANCE
Phone: (33) 1 41 42 20 35
Fax: (33) 1 41 42 20 01
Email:
contact@metabolic-syndrome-institute.org
Website:
http://www.metabolic- syndrome-institute.org |
|
